Fundraising leverage Mary Crowley Cancer Research has a clear donor-driven funding model with 100 percent of contributions benefiting patients, offering a compelling story for corporate giving programs and foundation partnerships to support clinical trials and patient assistance.

Personalized medicine niche The center specializes in personalized gene and immune-based cancer therapies and conducts Phase I/II trials, presenting an opportunity to partner on precision medicine initiatives, data collaboration, and sponsored research programs.

Nonprofit collaboration As a 501(c)3 nonprofit with over two decades of FDA-guideline compliant research, there is potential to pitch multi-year sponsorships, in-kind contributions, or joint marketing with healthcare suppliers and philanthropic entities.

Board & leadership access Recent expansions in governance and executive leadership (new CEO and board appointments) create openings for advisory partnerships, executive networking sponsorships, and high-visibility engagement with governance-focused donors and sponsors.

Strategic funding visibility Recent $50K donations and ongoing philanthropic support from notable trusts and financial institutions indicate opportunities to offer grant administration, programmatic funding packages, and named funding opportunities tied to specific cancer types or patient assistance programs.